Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

299.23
Delayed Data
As of Aug 17
 -3.77 / -1.24%
Today’s Change
176.36
Today|||52-Week Range
305.95
+36.26%
Year-to-Date

Stock Price Forecast

The 24 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 310.50, with a high estimate of 389.00 and a low estimate of 250.00. The median estimate represents a +3.77% increase from the last price of 299.23.

Analyst Recommendations

The current consensus among 29 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$3.62
Sales
$2.2B
Reporting Date
Nov 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.66%
 
 
 
 
 
 
Growthannually 9.39%
 
 
 
 
 
 

Sales

Growthquarterly 1.34%
 
 
 
 
 
 
Growthannually 15.76%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.